• Users Online: 212
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 39  |  Issue : 3  |  Page : 138-145

Neurological manifestations and mortality in hospitalized coronavirus disease 2019 patients


1 Department of Neurology, Akdeniz University Faculty of Medicine, Antalya, Türkiye
2 Department of Infectious Diseases, Akdeniz University, Antalya, Türkiye
3 Department of Biostatistics, Akdeniz University, Antalya, Türkiye

Correspondence Address:
Tugba Ozel
Department of Neurology, Akdeniz Universitesi Faculty of Medicine, Pınarbaşı, Antalya 07070
Türkiye
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/nsn.nsn_117_21

Rights and Permissions

Purpose: The purpose of the study is to analyze the neurological manifestations and to determine the association between these symptoms and mortality in hospitalized patients with coronavirus disease 2019 (COVID-19). Materials and Methods: Five hundred and forty-seven hospitalized patients with positive reverse transcriptase-polymerase chain reaction tests for severe acute respiratory syndrome coronavirus in a nasopharyngeal swab were included in this study. The demographic features, laboratory data, and radiologic imaging, neurological symptoms of hospitalized patients with COVID-19 were collected. Results: Of 547 hospitalized COVID-19 patients, the median age was 61 (range 18–93), 61.4% were male. Three hundred and forty-seven (63.4%) patients had a severe infection and 200 (36.6%) patients had a mild infection. Eighty-eight patients (16.1%) died during hospitalization. One hundred and fifty-four (28.2%) patients had at least one neurological symptom. Thirty-five (6.4%) patients manifested with only neurological symptoms at hospital admission. The most frequent neurological symptoms were headache (15.2%), taste and smell disorders (9.1%), and myalgia (6.6%). The other initial neurological manifestations were acute cerebral ischemic stroke, impaired consciousness, epileptic seizure, and posterior reversible encephalopathy. The late-onset neurological complications were autoimmune encephalitis and Guillain-Barre syndrome. The neurological manifestation was linked to the severity of disease (P = 0.005) but not correlated with mortality (P = 0.137). Conclusion: Neurological symptoms were frequent in COVID-19 patients. The neurological symptoms can be the initial symptoms or can be late-onset complications of COVID-19.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1414    
    Printed47    
    Emailed0    
    PDF Downloaded82    
    Comments [Add]    

Recommend this journal